Drug Profile
Diabetes type 1 vaccine - Corixa
Alternative Names: Anervax.DB; DiavaXLatest Information Update: 04 Nov 2002
Price :
$50
*
At a glance
- Originator Corixa Corporation
- Class Antihyperglycaemics; Diabetes mellitus vaccines; Vaccines
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Type 1 diabetes mellitus
Most Recent Events
- 04 Nov 2002 Discontinued - Preclinical for Type-1 diabetes mellitus in USA (unspecified route)
- 12 May 2000 Anervax.DBTM is available for licensing (http://www.corixa.com)
- 23 Feb 1999 Anergen is now part of Corixa Corporation